Anti-proliferative and cytotoxic effect of cannabidiol on human cancer cell lines in presence of serum
Abstract Objective: Cannabinoids are able to reduce tumor growth in xenograft models, but their therapeutic potential as anti-cancer drugs in…
Colon cancer
Small Nucleolar RNA, C/D Box 16 (SNORD16) Acts as a Potential Prognostic Biomarker in Colon Cancer
Abstract Colon cancer (CC) is considered one of the most common and lethal malignancies occurring both in male and female.…
Cannabidiol—from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer
Abstract Cannabis sativa L. is a plant long used for its textile fibers, seed oil, and oleoresin with medicinal and…
LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers
Abstract Background: Layilin (LAYN) is a critical gene that regulates T cell function. However, the correlations of LAYN to prognosis…
Integrative analysis of oncogenic fusion genes and their functional impact in colorectal cancer
Abstract Background: Fusion genes are good candidates of molecular targets for cancer therapy. However, there is insufficient research on the…
CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway
Abstract The pharmacological activation of the cannabinoid receptor type 2, CB2, has been shown to elicit anti-tumoral mechanisms in different…